Evidence map›Paper›PMID 28957993›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2018

An International Perspective on Chronic Multimorbidity: Approaching the Elephant in the Room.

Davide L Vetrano, Amaia Calderón-Larrañaga, Alessandra Marengoni, Graziano Onder, Jürgen M Bauer, Matteo Cesari, Luigi Ferrucci, Laura Fratiglioni

Open access · hybridAbstract readConference Proceedings
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 4 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 4 syntheses or guidelines pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Promoting physical activity with self-management support for those with multimorbidity: a randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021
    Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Davide L VetranoAging Research Center, Karolinska Institutet and Stockholm University, Sweden.
Amaia Calderón-LarrañagaAging Research Center, Karolinska Institutet and Stockholm University, Sweden.
Alessandra MarengoniAging Research Center, Karolinska Institutet and Stockholm University, Sweden.
Graziano OnderDepartment of Geriatrics, Catholic University of Rome, Italy.
Jürgen M BauerCenter for Geriatric Medicine, University of Heidelberg, Germany.
Matteo CesariGérontopôle, Centre Hospitalier Universitaire de Toulouse III, France.
Luigi FerrucciIntramural Research Program, National Institute on Aging, Baltimore, Maryland.
Laura FratiglioniAging Research Center, Karolinska Institutet and Stockholm University, Sweden.
Karolinska Institutet · SEHeidelberg University · DENational Institute on Aging · USStockholm Gerontology Research Center Foundation · SEUniversità Cattolica del Sacro Cuore · ITUniversité Toulouse III - Paul Sabatier · FRUniversity of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multimorbidity is a common and burdensome condition that may affect quality of life, increase medical needs, and make people live more years of life with disability. Negative outcomes related to multimorbidity occur beyond what we would expect from the summed effect of single conditions, as chronic diseases interact with each other, mutually enhancing their negative effects, and eventually leading to new clinical phenotypes. Moreover, multimorbidity mirrors an accelerated global susceptibility and a loss of resilience, which are both hallmarks of aging. Due to the complexity of its assessment and definition, and the lack of clear evidence steering its management, multimorbidity represents one of the main current challenges for clinicians, researchers, and policymakers. The authors of this article recently reflected on these issues during two twin international symposia at the 2016 European Union Geriatric Medicine Society (EUGMS) meeting in Lisbon, Portugal, and the 2016 Gerontological Society of America (GSA) meeting in New Orleans, USA. The present work summarizes the most relevant aspects related to multimorbidity, with the ultimate goal to identify knowledge gaps and suggest future directions to approach this condition.

Indexed as

AgingMultimorbidityAgedChronic DiseaseDelivery of Health CareEuropean UnionFrailtyGeriatricsHumansInternationalityPortugalPractice Guidelines as TopicQuality of LifeSocieties, MedicalUnited States

Identifiers

PMID28957993
PMCPMC6132114
OpenAlexW2754415896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.